
Immunovant Inc is a clinical-stage biopharmaceutical company. It is focused on enabling normal lives for patients with autoimmune diseases. The company's product includes IMVT-1401 targets the neonatal Fc receptor (FcRn). Immunovant Inc is a clinical-stage biopharmaceutical company. It is focused on enabling normal lives for patients with autoimmune diseases. The company's product includes IMVT-1401 targets the neonatal Fc receptor (FcRn).
期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 1.51 | 8.34254143646 | 18.1 | 20.7 | 17.65 | 997884 | 19.52969264 | CS |
4 | 0.31 | 1.60621761658 | 19.3 | 21.66 | 17.65 | 1094314 | 19.90072867 | CS |
12 | -7.77 | -28.3783783784 | 27.38 | 28.08 | 17.65 | 1215250 | 22.12671807 | CS |
26 | -9.91 | -33.5704607046 | 29.52 | 32.1 | 17.65 | 995464 | 25.12481733 | CS |
52 | -12.08 | -38.1192805301 | 31.69 | 35.97 | 17.65 | 1048922 | 27.27349402 | CS |
156 | 14.07 | 253.971119134 | 5.54 | 45.58 | 3.145 | 1105314 | 24.89272163 | CS |
260 | 4.63 | 30.9078771696 | 14.98 | 53.75 | 3.145 | 966832 | 22.57772556 | CS |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約